Advertisement
Screener

Protagenic Therapeutics, Inc.\new (PTIX) Debtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net

Protagenic Therapeutics, Inc.\new Debtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net

Protagenic Therapeutics, Inc.\new (PTIX) reported Debtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net of $0 for the 12-month period ending 2015-06-30, per its 10-K filed 2015-09-25.

Discontinued › Income Statement › Other Income

us-gaap:DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1 · last filed 2015-09-25

  • Protagenic Therapeutics, Inc.\new debtor reorganization items, gain (loss) on settlement of other claims, net for the quarter ending 2015-06-30 was $0.00.
  • Protagenic Therapeutics, Inc.\new debtor reorganization items, gain (loss) on settlement of other claims, net for the quarter ending 2015-03-31 was $0.00.
  • Protagenic Therapeutics, Inc.\new debtor reorganization items, gain (loss) on settlement of other claims, net for the quarter ending 2014-12-31 was $0.00.
  • Protagenic Therapeutics, Inc.\new debtor reorganization items, gain (loss) on settlement of other claims, net for the quarter ending 2014-09-30 was $0.00.
  • Protagenic Therapeutics, Inc.\new debtor reorganization items, gain (loss) on settlement of other claims, net for fiscal 2015 was $0.00.
  • Protagenic Therapeutics, Inc.\new debtor reorganization items, gain (loss) on settlement of other claims, net for fiscal 2014 was $0.00.
Period endDebtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net 3 monthDebtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net 6 monthDebtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net 9 monthDebtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net 12 month
2015-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25
$0.00
derived: sum of 2 quarters · filed 2015-09-25
$0.00
derived: sum of 3 quarters · filed 2015-09-25
$0.00
10-K · filed 2015-09-25
2015-03-31$0.00
10-Q · filed 2015-05-11
$0.00
derived: sum of 2 quarters · filed 2015-05-11
$0.00
10-Q · filed 2015-05-11
$0.00
derived: sum of 4 quarters · filed 2015-09-25
2014-12-31$0.00
10-Q · filed 2015-02-06
$0.00
10-Q · filed 2015-02-06
$0.00
derived: sum of 3 quarters · filed 2015-09-25
$0.00
derived: sum of 4 quarters · filed 2015-09-25
2014-09-30$0.00
10-Q · filed 2014-11-13
$0.00
derived: sum of 2 quarters · filed 2015-09-25
$0.00
derived: sum of 3 quarters · filed 2015-09-25
$0.00
derived: sum of 4 quarters · filed 2015-09-25
2014-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25
$0.00
derived: sum of 2 quarters · filed 2015-09-25
$0.00
derived: sum of 3 quarters · filed 2015-09-25
$0.00
10-K · filed 2015-09-25
2014-03-31$0.00
10-Q · filed 2015-05-11
$0.00
derived: sum of 2 quarters · filed 2015-05-11
$0.00
10-Q · filed 2015-05-11
2013-12-31$0.00
10-Q · filed 2015-02-06
$0.00
10-Q · filed 2015-02-06
2013-09-30$0.00
10-Q · filed 2014-11-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
CDT Equity Inc. (CDT)United States$0.000B-0.01
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Aditxt, Inc. (ADTX)United States$0.000B
Rafael Holdings, Inc. (RFL)United States$0.000B-0.00